Proofpoint Capital

Proofpoint Capital is a specialized investment firm focused on the life sciences, healthcare, and technology sectors. The firm provides growth capital and strategic support to both private and public companies developing transformative therapies, medical devices, and digital health solutions. Leveraging deep domain expertise and a fundamental research-driven approach, Proofpoint Capital identifies high-impact opportunities that aim to improve patient outcomes and clinical efficiency. Their portfolio includes notable investments in biotechnology companies specializing in immunology, oncology, and rare diseases. The firm is headquartered in New York and is led by experienced professionals from the healthcare and financial services industries.